Is today’s 10% decline a buying opportunity for this falling knife?

Despite today’s declines, this company has a bright outlook.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in engineering group Melrose (LSE: MRO) are sliding today after the company published a downbeat trading statement.

The company, which operates a private equity-style business model buying struggling engineering businesses and working to turn them around before a sale, reported today that its two subsidiaries are facing significant headwinds. 

The group said its Nortek subsidiary faces currency headwinds in 2018 and that the market for the Brush unit has been “very difficult“. 

Brush, which manufactures electricity generating equipment for the power generation, industrial, oil & gas and offshore sectors, has been impacted by wider industry trends and has been a thorn in the group’s side for some time now. 

Meanwhile, Nortek, which makes air management, security and home automation devices is suffering from exchange rate movements on products imported from China. 

Still, revenues in the period from 1 July to 29 October were up 3% year-on-year, and a  full review of Brush is currently under way to improve performance. 

Temporary setback

On the back of today’s news, shares in Melrose slumped by 9.7% in early deals before paring losses to trade down only 6% at the time of writing. However, I believe that these declines present an excellent opportunity for investors to buy into the Melrose story. 

It has a history of producing outsized returns for investors. Since inception in 2003, the company has acquired a handful of struggling businesses at knockdown prices before instigating a turnaround and selling the companies. 

Management is extremely good at this process having generated £5.2bn in shareholder value since 2003. The average annual return on investment during the period is 26%. 

Considering this historical performance, I’m confident that the current headwinds are only temporary. Even though Brush has been a problem area for some time, at the end of August, the firm reported that progress at Nortek is going to plan with £47m spent to cut staffing levels by 5% and boost profit margins by a third. Further margin expansion is expected in the years ahead. 

Placing a value on growth 

Even though I’m positive on the outlook for Melrose, it’s difficult to value the company’s shares. On a P/E basis, the shares trade at a forward multiple of 22.1, which looks expensive. However, the whole business model is based not on earnings growth, but book value growth through the transformation and sale of businesses. 

The average City estimate puts the current value of its business portfolio at 260p, with a bull case scenario of 290p, nearly 35% above the current price. It will take time for management to unlock this value, so investors shouldn’t expect a sudden share price rally overnight, but these figures show that the value is there.  

The bottom line 

Overall, today’s update is disappointing, but I believe it does not detract from the company’s long-term growth story. 

Melrose has a long history of producing impressive returns for investors, and progress at Nortek shows that the group hasn’t lost its edge. Over the next few years, investors should be able to reap the benefits, as they have in the past. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK owns shares of Melrose. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »